These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 8769179

  • 21. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
    Hiesse C, Rousseau P, Kriaa F, Larue JR, Charpentier B.
    Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS, Woodle ES, Newell KA, Millis JM, Cronin DC, Loss GE, Grewal HP, Siegel CT, Pellar S, Josephson MA, Thistlethwaite JR.
    Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sequential pancreas after kidney transplantation: is anti-lymphocyte induction therapy needed?
    Stratta RJ.
    Transplant Proc; 1998 Jun; 30(4):1549-51. PubMed ID: 9636629
    [No Abstract] [Full Text] [Related]

  • 28. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine.
    Sutherland DE, Moudry-Munns KC, Gruessner A.
    Transplant Proc; 1994 Oct; 26(5):2752-5. PubMed ID: 7940866
    [No Abstract] [Full Text] [Related]

  • 29. Predictors of improved outcome in second pediatric renal transplant recipients.
    Moss A, Almond PS, Matas AJ, Gillingham K, Najarian JS.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):597. PubMed ID: 8438429
    [No Abstract] [Full Text] [Related]

  • 30. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
    van Gelder T, Zietse R, Yzermans JN, Rischen-Vos J, Vaessen LM, Weimar W.
    Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effect of cyclosporine A on the outcome of one-haplotype identical kidney grafts from a living related donor.
    Papadimitriou M, Vakianis P, Malliara M, Economidou D, Alexopoulos E, Belechri AM, Koukoudis P, Papadopoulou D, Syrganis C, Polymenidis Z.
    Transplant Proc; 1994 Oct; 26(5):2548-9. PubMed ID: 7940786
    [No Abstract] [Full Text] [Related]

  • 35. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
    Knight RJ, Kerman RH, Podder H, Katz SM, Van Buren CT, Kahan BD.
    Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
    [Abstract] [Full Text] [Related]

  • 36. Renal transplantation in cyclosporine-treated patients over age 50.
    Riera L, Serón D, Castelao AM, Griñó JM, Franco E, Bover J, Vigués L, Alsina J, Serrallach N.
    Transplant Proc; 1992 Feb; 24(1):122-3. PubMed ID: 1539204
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM, Sánchez P, Sánchez J, García J, Orero E, Beneyto I, Cruz JM.
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract] [Full Text] [Related]

  • 39. Donor-specific transfusion for kidney transplantation in the cyclosporine era.
    Inoue S, Aikawa M, Dobashi Y, Kuzuhara K, Yanagisawa T, Ootubo O, Mimura N.
    Transplant Proc; 1996 Jun; 28(3):1220-1. PubMed ID: 8658633
    [No Abstract] [Full Text] [Related]

  • 40. Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience.
    Pham SM, Kormos RL, Kawai A, Murali S, Hattler BG, Demetris AJ, Griffith BP.
    Transplant Proc; 1996 Apr; 28(2):1002-4. PubMed ID: 8623208
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.